Select Drug Profiles

FDA Approvals, Select Drug Profiles

Welireg FDA Approved for 3 Tumor Types Associated with von Hippel-Lindau Disease

FDA Approvals, Select Drug Profiles

Jakafi a New Treatment Option for Chronic Graft-versus-Host Disease

FDA Approvals, Select Drug Profiles

Rezurock Novel Oral Therapy FDA Approved for Chronic Graft-versus-Host Disease

FDA Approvals, Select Drug Profiles

Opdivo First FDA-Approved Immunotherapy for First-Line Treatment of Advanced Gastric Cancer

FDA Approvals, Select Drug Profiles

Keytruda Received FDA Approval for First-Line Treatment of HER2-Positive Advanced Gastric Cancer

FDA Approvals, Select Drug Profiles

Trodelvy Receives New Indication for Advanced Urothelial Cancer

FDA Approvals, Select Drug Profiles

Sarclisa Receives New Indication for Relapsed or Refractory Multiple Myeloma

FDA Approvals, Select Drug Profiles

FDA Alert: Pepaxto (Melphalan Flufenamide) Associated with Increased Risk of Death in Postmarketing Clinical Trial

FDA Approvals, Select Drug Profiles

Jemperli First FDA-Approved Immunotherapy for Advanced Endometrial Cancer with dMMR Biomarker

FDA Approvals, Select Drug Profiles

Rybrevant First FDA-Approved Therapy for NSCLC with EGFR Exon 20 Insertion Mutations

1
2
3
4

Page 1 of 13
Results 1 - 10 of 121

SUBSCRIBE

© Amplity Health. All rights reserved.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Print Edition

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.